NDV-3 Protects Mice From Vulvovaginal Candidiasis Through T- and B-Cell Immune Response

類似資料

• Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
  著者:: Priya Uppuluri, 等
  出版事項: (2018-06-01)
• Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis
  著者:: Uppuluri, Priya, 等
  出版事項: (2018)
• Isavuconazole Therapy Protects Immunosuppressed Mice from Mucormycosis
  著者:: Luo, Guanpingsheng, 等
  出版事項: (2014)
• Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis
  著者:: Luo, Guanpingsheng, 等
  出版事項: (2011)
• A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
  著者:: Edwards, John E, 等
  出版事項: (2018)